Skip to content

Food as Medicine: A Quasi-Randomized Control Trial of Healthy Foods for Chronic Disease Management

Food as Medicine: A Quasi-Randomized Control Trial of Healthy Foods for Chronic Disease Management

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05174078
Enrollment
70
Registered
2021-12-30
Start date
2022-02-01
Completion date
2023-12-30
Last updated
2024-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Obesity, Pre-diabetes, Type 2 Diabetes

Brief summary

The purpose of this study is to investigate the effect of providing healthy foods and nutrition education on participants' body weight, blood pressure, and average blood sugar level. The healthy food offerings tested in this study will help determine which option is best to improve health outcomes among Cleveland Clinic Akron General patients with chronic conditions. Findings from this study could guide doctors in deciding on appropriate nutrition and dietitian services for Cleveland Clinic patients.

Detailed description

Participants will receive healthy food items for 15 weeks and nutrition counseling and education to support chronic disease management at no cost. The healthy food items will consist of either medically-tailored pre-prepared meals, or a weekly produce box with recipes depending on the study arm. Participants must complete a baseline study visit, one nutritional counseling session via phone, 2 to 4 nutrition education videos, and a 16-week post-intervention study visit.

Interventions

OTHERMedically-tailored meals

Medically tailored meals delivered to patients' homes for 15 weeks AND one medical nutrition therapy session with a dietician + viewership of 2 to 4 nutrition education videos.

OTHERProduce box and recipes

Weekly produce box and access to recipes via internet for 15 weeks AND one medical nutrition therapy session with a dietician + viewership of 2 to 4 nutrition education videos.

Sponsors

The Cleveland Clinic
CollaboratorOTHER
The University of Akron
CollaboratorOTHER
Cleveland Clinic Akron General
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

A quasi-randomized control trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults 18 years of age or older who are patients at Akron General Center for Family Medicine * Have body mass index (BMI) equal to or greater that 30kg/m2 AND * Have at least one of the following diagnoses determined based on patients' problem list in the electronic medical record (EMR) and the international classification of diseases, 10th revision (ICD-10) codes: 1. Pre-type 2 diabetes mellitus 2. Type 2 diabetes mellitus 3. Hypertension * Have NOT participated in nutrition counseling at the University of Akron Nutrition Center within the past 6 months

Exclusion criteria

* Food allergies * Pregnant * No access to internet * Need English language interpretation * Currently participating in a structured weight loss program or using weight loss medications * Any condition that, in the Investigator's judgement, interferes with the ability to adhere to study requirements.

Design outcomes

Primary

MeasureTime frameDescription
Change in participants' body weightFrom baseline visit (W1) to 16 week visit and at 6 months and 12 months from baselinePercent weight loss

Secondary

MeasureTime frameDescription
Pre-type 2 diabetes mellitus: Change in medication dosageFrom baseline visit (W1) to 16 week visit and at 6 months and 12 months from baselinePercent change in medication dosage
Pre-type 2 diabetes mellitus: Change in HbA1cFrom baseline visit (W1) to 16 week visit and at 6 months and 12 months from baselineAbsolute change in HbA1c
Type 2 diabetes mellitus: Change in number of medicationsFrom baseline visit (W1) to 16 week visit and at 6 months and 12 months from baselineAbsolute change in number of medications
Type 2 diabetes mellitus: Change in medication dosageFrom baseline visit (W1) to 16 week visit and at 6 months and 12 months from baselinePercent change in medication dosage
Type 2 diabetes mellitus: Change in HbA1cFrom baseline visit (W1) to 16 week visit and at 6 months and 12 months from baselineAbsolute change in HbA1c
Hypertension: Change in number of medicationsBaseline visit (W1) to 16 week visitAbsolute change in number of medications
Pre-type 2 diabetes mellitus: Change in number of medicationsFrom baseline visit (W1) to 16 week visit and at 6 months and 12 months from baselineAbsolute change in number of medications
Receipt of healthy food items: The Hunger Vital Sign scaleBaseline visit (W1) to week 16 visitValues on the scale are: often true, sometimes true, and never true. A positive response to either or both of the first two values (often true, sometimes true) identifies households as being at risk for food insecurity
Receipt of healthy food items: Eating at America's Table scaleBaseline visit (W1) to week 16 visitEach reported frequency is expressed as a daily average ranging from 0 to 5. The estimate of the daily number of Pyramid/MyPyramid servings is calculated as average daily frequency x the number of Pyramid/MyPyramid servings for the portion size, summed across all food groups. A higher score for fruits and vegetables indicates a better outcome.
Receipt of healthy food items: Patient Health Questionnaire-8 Depression ScaleBaseline visit (W1) to week 16 visitEight items, each of which is scored 0 to 3, providing a 0 to 24 severity score. Overall score is the sum of the 8 items. A score of 10 or greater is considered major depression, 20 or more is severe major depression.
Nutrition Education: Healthy Eating and Weight Self-Efficacy ScaleBaseline visit (W1) to 16-week visitValues on the scale are: Strongly disagree, disagree, neutral, agree, and strongly agree. Responses of agree and strongly agree indicate a better outcome.
Nutrition Education: Self-Efficacy for Managing Chronic Diseases ScaleBaseline visit (W1) to 16-week visitSix items, each of which is scored 0 to 10. Overall score is the mean of the 6 items. A higher score indicates a better outcome.
Hypertension: Change in medication dosageBaseline visit (W1) to 16 week visitPercent change in medication dosage

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026